.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Levocetirizine dihydrochloride - Generic Drug Details

« Back to Dashboard
Levocetirizine dihydrochloride is the generic ingredient in two branded drugs marketed by Apotex Inc, Synthon Pharms, Micro Labs Ltd India, Sciegen Pharms Inc, Sun Pharm Inds Ltd, Ucb Inc, Sun Pharma Global, L Perrigo Co, Hetero Labs Ltd Iii, Macleods Pharms Ltd, Taro Pharm Inds, Glenmark Generics, Sandoz, Dr Reddys Labs Ltd, and Teva Pharms, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for levocetirizine dihydrochloride. Twenty-seven suppliers are listed for this compound.

Summary for Generic Name: levocetirizine dihydrochloride

Tradenames:2
Patents:0
Applicants:15
NDAs:17
Drug Master File Entries: see list12
Suppliers / Packaging: see list27
Therapeutic Class:Respiratory Tract Agents
Drug Prices:see low prices

Pharmacology for Ingredient: levocetirizine dihydrochloride

Clinical Trials for: levocetirizine dihydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd
LEVOCETIRIZINE DIHYDROCHLORIDE
levocetirizine dihydrochloride
TABLET;ORAL201653-001Jun 26, 2015RXNo
Teva Pharms
LEVOCETIRIZINE DIHYDROCHLORIDE
levocetirizine dihydrochloride
TABLET;ORAL090199-001Aug 22, 2011RXNo
Ucb Inc
XYZAL
levocetirizine dihydrochloride
TABLET;ORAL022064-001May 25, 2007RXYes
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: levocetirizine dihydrochloride

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ucb Inc
XYZAL
levocetirizine dihydrochloride
SOLUTION;ORAL022157-001Jan 28, 20085,698,558*PED<disabled>
Ucb Inc
XYZAL
levocetirizine dihydrochloride
TABLET;ORAL022064-001May 25, 20075,698,558*PED<disabled>
Ucb Inc
XYZAL
levocetirizine dihydrochloride
TABLET;ORAL022064-001May 25, 20074,525,358<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc